Savita Subramanian, head of U.S. equity and quantitative strategy for BofA, doesn’t see “any reason to continue to buy ...

Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

Semiconductors put in a powerful performance in Q2 2026, which more than made up for what happened in Q1 2026. Read more on ...

Detailed price information for Foster L B Company (FSTR-Q) from The Globe and Mail including charting and trades.